New Zealand Companies Out of the 'Chillybin'
Client Alert | less than 1 min read | 08.19.15
On August 12, the U.S. in a Federal Register notice confirmed that it "has agreed to waive discriminatory purchasing requirements for eligible products and suppliers of New Zealand beginning on August 12, 2015," due to the WTO's approval of New Zealand as a member of the WTO Agreement on Government Procurement (GPA). Joining the 43-member GPA will provide new access to the U.S. federal marketplace for New Zealand-based companies, including "designated country" status under the Trade Agreements Act, and will open immediate doors to federal government contracting opportunities, including GSA and VA Schedule contracts, that generally limit acquisition to end products that are manufactured or substantially transformed in the U.S. or a "designated country."
Contacts
Insights
Client Alert | 5 min read | 05.12.26
EU Pharma Package: Advertising Compromise Proposal
In our ninth alert in this EU Pharma Package Series, we discussed the proposals of the Commission, Council, and Parliament with respect to advertising of medicinal products.
Client Alert | 6 min read | 05.11.26
FDA’s AI in Early Phase Clinical Trials RFI: An Opportunity to Help Set the Rules of the Road
Client Alert | 4 min read | 05.11.26
New Temporary State Aid Framework Throws A Lifeline To Sectors Hit By The Middle East Crisis
Client Alert | 4 min read | 05.11.26



